Determination of soluble CD21 as a parameter of B cell activation
暂无分享,去创建一个
W. Prodinger | C. Larcher | A. Petzer | M. Mitterer | N. Falser | H. Huemer
[1] J. Bonnefoy,et al. CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.
[2] N. Ling,et al. Properties of soluble CR2 in human serum. , 1992, Immunobiology.
[3] T. Osato,et al. Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus. , 1992, Virology.
[4] R. Rothlein,et al. A form of circulating ICAM-1 in human serum. , 1991, Journal of immunology.
[5] D. Fearon,et al. Suppression of the immune response by a soluble complement receptor of B lymphocytes. , 1991, Science.
[6] N. Ling,et al. Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia , 1991, Clinical and experimental immunology.
[7] M. Kazatchkine,et al. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. , 1991, Journal of immunology.
[8] D. Tuveson,et al. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19 , 1991, The Journal of experimental medicine.
[9] G. Duff,et al. A soluble form of the interleukin‐1 receptor produced by a human B cell line , 1990, FEBS letters.
[10] B. Myones,et al. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. , 1990, The Journal of biological chemistry.
[11] T. Nutman,et al. Serum levels of IgE‐binding factor (soluble CD23) in diseases associated with elevated IgE , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[12] M. Dierich,et al. Human complement factor H: An additional gene product of 43kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement , 1989, European journal of immunology.
[13] H. Mikola,et al. The synthesis and use of activated N-benzyl derivatives of diethylenetriaminetetraacetic acids: alternative reagents for labeling of antibodies with metal ions. , 1989, Analytical biochemistry.
[14] N. Ling,et al. Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia. , 1989, Immunology letters.
[15] B. Chain,et al. Endopeptidase activities associated with the plasma membrane compartment of an antigen-presenting B cell. , 1989, Clinical and experimental immunology.
[16] N. Cooper,et al. CR2 ligands modulate human B cell activation. , 1988, Journal of immunology.
[17] I Hemmilä,et al. Lanthanides as probes for time-resolved fluorometric immunoassays. , 1988, Scandinavian journal of clinical and laboratory investigation.
[18] John D Lambris,et al. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies , 1988, European journal of immunology.
[19] J. Hatzfeld,et al. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. , 1988, Journal of immunology.
[20] T. Schulz,et al. Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion. , 1988, Immunology.
[21] L. Lagneaux,et al. Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. , 1988, Blood.
[22] B. Myones,et al. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site. , 1987, Complement.
[23] S. Lemon,et al. A SECOND SITE FOR EPSTEIN-BARR VIRUS SHEDDING: THE UTERINE CERVIX , 1986, The Lancet.
[24] D. Bentley,et al. Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteins. , 1986, Immunology today.
[25] L. Young,et al. EPSTEIN-BARR VIRUS RECEPTORS ON HUMAN PHARYNGEAL EPITHELIA , 1986, The Lancet.
[26] G. Nemerow,et al. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. , 1985, Journal of immunology.
[27] J. Platt,et al. Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro. , 1985, Blood.
[28] G. Nemerow,et al. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2) , 1985, Journal of virology.
[29] F. Melchers,et al. The action of human C3 in soluble or cross‐linked form with resting and activated murine B lymphocytes , 1985, European journal of immunology.
[30] R. Frade,et al. Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule , 1985, European journal of immunology.
[31] P. A. Biro,et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[32] D. Fearon,et al. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[33] V. Nussenzweig,et al. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody , 1983, The Journal of experimental medicine.
[34] R. DiSipio,et al. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. , 1983, Journal of immunology.
[35] E Soini,et al. Time-resolved fluorometer for lanthanide chelates--a new generation of nonisotopic immunoassays. , 1983, Clinical chemistry.
[36] P. Lobo,et al. In vitro studies on the immune regulatory role of complement receptors (C3) present on human B lymphocytes , 1982, European journal of immunology.
[37] J. Lambris,et al. Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Genco,et al. Inhibition of lymphocyte blastogenesis by C3c and C3d. , 1979, Journal of immunology.
[39] K. Hartmann,et al. Stimulation of murine B lymphocytes by isolated C3b , 1975, The Journal of experimental medicine.
[40] H. Grey,et al. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. , 1973 .